Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NOVN

Novan (NOVN) Stock Price, News & Analysis

Novan logo

About Novan Stock (NASDAQ:NOVN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
7.19 million shs
Average Volume
602,421 shs
Market Capitalization
$2.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NOVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novan and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NOVN Stock News Headlines

Novartis AG
Novartis AG Registered Shares
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel
Novartis AG Registered Shares NOVN
Novan reaches deals to sell assets in bankruptcy case
Firm Retention Summary: Novan
See More Headlines

NOVN Stock Analysis - Frequently Asked Questions

Novan, Inc. (NASDAQ:NOVN) posted its earnings results on Monday, May, 15th. The company reported ($0.54) EPS for the quarter, missing the consensus estimate of ($0.32) by $0.22. The firm earned $3.17 million during the quarter, compared to the consensus estimate of $6.19 million. Novan had a negative net margin of 128.61% and a negative trailing twelve-month return on equity of 700.28%.
Read the conference call transcript
.

Novan (NOVN) raised $46 million in an initial public offering on Wednesday, September 21st 2016. The company issued 3,800,000 shares at a price of $11.00-$13.00 per share. Piper Jaffray served as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Novan investors own include Meta Platforms (META), Bionano Genomics (BNGO), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), NIO (NIO), Tesla (TSLA) and Zomedica (ZOM).

Company Calendar

Last Earnings
5/15/2023
Today
8/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NOVN
CIK
1467154
Employees
90
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
($1.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.31 million
Net Margins
-128.61%
Pretax Margin
-128.39%
Return on Equity
-700.28%
Return on Assets
-39.58%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.74
Quick Ratio
0.72

Sales & Book Value

Annual Sales
$24.71 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.19 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
28,015,000
Free Float
27,651,000
Market Cap
$2.64 million
Optionable
Not Optionable
Beta
-0.06

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:NOVN) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners